Our data also demonstrate a reduction in eNOS phosphorylation in skeletal muscle tissue of T2DM with insulin stimulation which together with the concomitant increase in ET‐1 protein expression may explain the impaired FID in T2DM subjects. The gene discussed is EDN1; the disease is type 2 diabetes mellitus.